Literature DB >> 22227394

An analog of BIX-01294 selectively inhibits a family of histone H3 lysine 9 Jumonji demethylases.

Anup K Upadhyay1, Dante Rotili, Ji Woong Han, Ruogu Hu, Yanqi Chang, Donatella Labella, Xing Zhang, Young-Sup Yoon, Antonello Mai, Xiaodong Cheng.   

Abstract

BIX-01294 and its analogs were originally identified and subsequently designed as potent inhibitors against histone H3 lysine 9 (H3K9) methyltransferases G9a and G9a-like protein. Here, we show that BIX-01294 and its analog E67 can also inhibit H3K9 Jumonji demethylase KIAA1718 with half-maximal inhibitory concentrations in low micromolar range. Crystallographic analysis of KIAA1718 Jumonji domain in complex with E67 indicated that the benzylated six-membered piperidine ring was disordered and exposed to solvent. Removing the moiety (generating compound E67-2) has no effect on the potency against KIAA1718 but, unexpectedly, lost inhibition against G9a-like protein by a factor of 1500. Furthermore, E67 and E67-2 have no effect on the activity against histone H3 lysine 4 (H3K4) demethylase JARID1C. Thus, our study provides a new avenue for designing and improving the potency and selectivity of inhibitors against H3K9 Jumonji demethylases over H3K9 methyltransferases and H3K4 demethylases.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22227394      PMCID: PMC3280428          DOI: 10.1016/j.jmb.2011.12.036

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  31 in total

1.  JmjC: cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2beta.

Authors:  P M Clissold; C P Ponting
Journal:  Trends Biochem Sci       Date:  2001-01       Impact factor: 13.807

2.  Multiparametric scaling of diffraction intensities.

Authors:  Zbyszek Otwinowski; Dominika Borek; Wladyslaw Majewski; Wladek Minor
Journal:  Acta Crystallogr A       Date:  2003-04-25       Impact factor: 2.290

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  JmjC-domain-containing proteins and histone demethylation.

Authors:  Robert J Klose; Eric M Kallin; Yi Zhang
Journal:  Nat Rev Genet       Date:  2006-09       Impact factor: 53.242

5.  Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase.

Authors:  Stefan Kubicek; Roderick J O'Sullivan; E Michael August; Eugene R Hickey; Qiang Zhang; Miguel L Teodoro; Stephen Rea; Karl Mechtler; Jennifer A Kowalski; Carol Ann Homon; Terence A Kelly; Thomas Jenuwein
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

6.  Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

Authors:  Dante Rotili; Antonello Mai
Journal:  Genes Cancer       Date:  2011-06

7.  Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase.

Authors:  Jean-François Couture; Evys Collazo; Patricia A Ortiz-Tello; Joseph S Brunzelle; Raymond C Trievel
Journal:  Nat Struct Mol Biol       Date:  2007-06-24       Impact factor: 15.369

Review 8.  Epigenetic modifications as therapeutic targets.

Authors:  Theresa K Kelly; Daniel D De Carvalho; Peter A Jones
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

9.  PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression.

Authors:  Wen Liu; Bogdan Tanasa; Oksana V Tyurina; Tian Yuan Zhou; Reto Gassmann; Wei Ting Liu; Kenneth A Ohgi; Chris Benner; Ivan Garcia-Bassets; Aneel K Aggarwal; Arshad Desai; Pieter C Dorrestein; Christopher K Glass; Michael G Rosenfeld
Journal:  Nature       Date:  2010-07-11       Impact factor: 49.962

10.  Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294.

Authors:  Yanqi Chang; Xing Zhang; John R Horton; Anup K Upadhyay; Astrid Spannhoff; Jin Liu; James P Snyder; Mark T Bedford; Xiaodong Cheng
Journal:  Nat Struct Mol Biol       Date:  2009-02-15       Impact factor: 15.369

View more
  21 in total

1.  Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell Studies.

Authors:  Sergio Valente; Veronica Rodriguez; Ciro Mercurio; Paola Vianello; Bruna Saponara; Roberto Cirilli; Giuseppe Ciossani; Donatella Labella; Biagina Marrocco; Giovanni Ruoppolo; Oronza A Botrugno; Paola Dessanti; Saverio Minucci; Andrea Mattevi; Mario Varasi; Antonello Mai
Journal:  ACS Med Chem Lett       Date:  2014-12-08       Impact factor: 4.345

Review 2.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

Review 3.  Epigenetic polypharmacology: A new frontier for epi-drug discovery.

Authors:  Daniela Tomaselli; Alessia Lucidi; Dante Rotili; Antonello Mai
Journal:  Med Res Rev       Date:  2019-06-20       Impact factor: 12.944

4.  Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.

Authors:  John R Horton; Amanda Engstrom; Elizabeth L Zoeller; Xu Liu; John R Shanks; Xing Zhang; Margaret A Johns; Paula M Vertino; Haian Fu; Xiaodong Cheng
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

5.  Structural investigations of the nickel-induced inhibition of truncated constructs of the JMJD2 family of histone demethylases using X-ray absorption spectroscopy.

Authors:  Nitai Charan Giri; Lisa Passantino; Hong Sun; Maria Antonietta Zoroddu; Max Costa; Michael J Maroney
Journal:  Biochemistry       Date:  2013-06-07       Impact factor: 3.162

6.  Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds.

Authors:  John R Horton; Xu Liu; Molly Gale; Lizhen Wu; John R Shanks; Xing Zhang; Philip J Webber; Joshua S K Bell; Stephen C Kales; Bryan T Mott; Ganesha Rai; Daniel J Jansen; Mark J Henderson; Daniel J Urban; Matthew D Hall; Anton Simeonov; David J Maloney; Margaret A Johns; Haian Fu; Ajit Jadhav; Paula M Vertino; Qin Yan; Xiaodong Cheng
Journal:  Cell Chem Biol       Date:  2016-07-14       Impact factor: 8.116

7.  Quantitative analysis of histone demethylase probes using fluorescence polarization.

Authors:  Wenqing Xu; Jessica D Podoll; Xuan Dong; Anthony Tumber; Udo Oppermann; Xiang Wang
Journal:  J Med Chem       Date:  2013-06-13       Impact factor: 7.446

Review 8.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310

9.  A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth.

Authors:  Lei Wang; Jianjun Chang; Diana Varghese; Michael Dellinger; Subodh Kumar; Anne M Best; Julio Ruiz; Richard Bruick; Samuel Peña-Llopis; Junjie Xu; David J Babinski; Doug E Frantz; Rolf A Brekken; Amy M Quinn; Anton Simeonov; Johnny Easmon; Elisabeth D Martinez
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Inhibition of Nuclear Receptor Binding SET Domain 2/Multiple Myeloma SET Domain by LEM-06 Implication for Epigenetic Cancer Therapies.

Authors:  Eric di Luccio
Journal:  J Cancer Prev       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.